CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Mar. 29, 2013	Mar. 30, 2012	Apr. 01, 2011
Cash flows from operating activities:
Net (loss) income	$ (40,629)	$ 7,598	$ 36,424
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation	134,133	101,507	83,629
Amortization of intangible assets	23,038	24,004	19,424
Deferred income taxes	(50,728)	(13,330)	(4,098)
Stock-based compensation expense	27,035	21,382	17,440
Loss on disposition of fixed assets	12,109	5,814	6,999
Non-cash loss on extinguishment of debt	6,726
Repayment of discount on the 2016 Notes	(3,418)
Receipt of premium on the Additional 2020 Notes	10,500
Other non-cash adjustments	4,301	1,793	503
Increase (decrease) in cash resulting from changes in operating assets and liabilities, net of effects of acquisitions:
Accounts receivable	(57,124)	(21,026)	(14,138)
Inventories	21,233	(25,271)	(14,030)
Other assets	(15,471)	(9,266)	3,151
Accounts payable	4,564	7,679	6,644
Accrued liabilities	9,406	33,280	32,441
Other liabilities	6,123	7,285	(4,772)
Net cash provided by operating activities	91,798	141,449	169,617
Cash flows from investing activities:
Purchase of property, equipment and satellites, net	(176,295)	(204,973)	(208,285)
Cash paid for patents, licenses and other assets	(25,270)	(24,049)	(15,986)
Payments related to acquisition of businesses, net of cash acquired			(13,456)
Net cash provided by (used in) investing activities	(201,565)	(229,022)	(237,727)
Cash flows from financing activities:
Proceeds from issuance of 2020 Notes	300,000	275,000
Repayment of 2016 Notes	(271,582)
Payment of debt issuance costs	(8,059)	(5,706)	(2,775)
Proceeds from line of credit borrowings		130,000	40,000
Payments on line of credit		(190,000)	(40,000)
Proceeds from issuance of common stock under equity plans	31,001	19,341	26,398
Purchase of common stock in treasury	(8,412)	(7,451)	(5,880)
Other		(1,386)
Incremental tax benefits from stock-based compensation	0	0	867
Net cash provided by (used in) financing activities	42,948	219,798	18,610
Effect of exchange rate changes on cash	(26)	(132)	359
Net (decrease) increase in cash and cash equivalents	(66,845)	132,093	(49,141)
Cash and cash equivalents at beginning of fiscal year	172,583	40,490	89,631
Cash and cash equivalents at end of fiscal year	105,738	172,583	40,490
Supplemental information:
Cash paid for interest (net of amounts capitalized)	32,004	5,964	2,797
Cash paid (received) for income taxes, net	931	(3,966)	(6,563)
Non-cash investing and financing activities:
Capitalization of estimated satellite performance incentives obligation	227	22,300
Issuance of stock in satisfaction of certain accrued employee compensation liabilities	7,060	6,340	5,096
Capitalization of non-cash portion of interest expense and stock-based compensation to constructed assets	520	3,802	3,261
Issuance of common stock in connection with acquisitions			4,630
Fair value of assets acquired in business combinations, excluding cash acquired			22,699
Liabilities assumed in business combinations			$ 4,613